Commissioned in the USA Apple Watch Series 9 And Watch Ultra 2 It turned out that the key name in the ban was “Marcelo Lamego”.
For those who missed it, the health-focused technology company Masimo Due to a long-standing patent dispute with Apple now Watch Series 9 and Watch Ultra 2 cannot be sold on US-based official sales channels. The incident centered on the sensor used in Apple Watches that measures the oxygen level in the blood. Apple’s ITC (US International Trade Commission) It has been determined that Masimo infringes its patents.. Due to this situation, Apple cannot sell in physical stores as well as online. He also appealed the ban imposed in order to resolve the process.. So how exactly did this incident start? According to Bloomberg’s news According to the process behind Apple An engineer hired by specifically Marcelo Lamego It is located. He sent an e-mail to Apple CEO Tim Cook and started working at Apple after subsequent meetings. Lamego, He was the chief technical officer at Cercacor Laboratories, a sister company of Masimo Corp, which imposed the ban in the US. When he left here, he learned things he had no knowledge of before, and learned in his new company. It carries information about measuring the oxygen level in the blood. Lamego, He resigned from Apple in July 2014, just a few months after taking the job. Masimo, who did not give up even though his working time was short, states that Lamego left after getting what Apple needed and highlights this situation in the legal process.
YOU MAY BE INTERESTED IN
According to Apple executive Steve Hotelling Marcelo Lamego He was never able to fully adapt to the company. Lamego argued constantly with managers, demanded multimillion-dollar budgets and wanted to be able to hire his own engineers without approval, Hotelling said in testimony in a lawsuit between the companies.
It is noteworthy that after his work at Apple, Lamego founded his own company, True Wearables. It is stated that Lamego launched a device called Oxxiom with this company in 2016, which it calls the world’s first continuous and disposable blood-oxygen sensor.
Masimo, as reported by Bloomberg, also filed a lawsuit against this initiative and filed a lawsuit over its patents. He obtained a court order preventing the product from being sold. In other words, Masimo closely followed the actions of his former employee, and as a result, the situation went as far as banning the products sold by a giant like Apple.
According to a claim made recently, Apple It is developing a software update to bypass the import ban in the USA. To avoid having to permanently stop device sales for Apple engineers, It is stated that they are racing to change the blood oxygen sensor algorithms in Apple Watch.
It is still not clear when the update, which is thought to remove the technology that is reported to violate Masimo patents, will arrive, but Masimo CEO Joe Kiani, who made a statement on the subject last week, said: He stated that he absolutely did not believe that Apple could solve the patent infringement problem with software.
According to Kiani, there is a hardware patent violation, not a software one. In this respect, “I don’t think this will work – nor should it – because our patents are not software related.” The manager said, It is reported that he spent 60 million dollars to ban the sales of “Watch” in the USA.